Phoenix Holdings Ltd. Neurocrine Biosciences Inc Transaction History

Phoenix Holdings Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$79.65 - $106.22 $1.3 Million - $1.73 Million	-16,281 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$86.18 - $99.03 $43,779 - $50,307	508 Added 3.22%	16,281 $1.53 Million
Q2 2021 Aug 10, 2021	BUY	$89.43 - $102.27 $495,352 - $566,473	5,539 Added 54.12%	15,773 $1.53 Million
Q1 2021 May 10, 2021	BUY	$87.57 - $119.4 $896,191 - $1.22 Million	10,234 New	10,234 $965,000

649

97.1M

749K

553K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.